UNSPSC 51284301: Azidamfenicol

This classification denotes an antibiotic with the molecular formula C11H13N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40257685LM, chemically known as acetamide, 2-azido-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)-, d-threo-(-)- but generally known as azidamfenicol, which bears US NIH Compound Identifier 62858. European Medicines Agency schedules Azidamfenicol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05654MIG.

UNSPSC 51284301 Azidamfenicol, a Commodity code, shows minimal alignment with recent state and local procurement activity. The code nominally covers a specific pharmaceutical antibiotic, but the opportunities tagged under it reflect a much broader pharmaceutical and medical supply procurement landscape: naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, emergency medical and first aid supplies for fire rescue operations, and generic multi-source pharmaceuticals distributed through cooperative purchasing networks. State and local governments are buying pharmaceutical products, medical consumables, and emergency response supplies across these recent solicitations, but azidamfenicol itself does not appear as a line item in any of them.

Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire departments (City of Tampa Fire Department), and state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, MMCAP). Recent opportunities span Florida, Texas, Minnesota, and Oregon, with activity concentrated in emergency medical supply procurement and statewide pharmaceutical distribution frameworks. Representative solicitations include Seminole County's IFB for naloxone and drug deactivation systems with a due date of July 26, 2023 (response deadline noted in source materials); the City of Tampa's IFB 26-P-00145 for medical and first aid supplies estimated at $700,000 with a March 13, 2026 response deadline and a small local business enterprise set-aside; and MMCAP's RFP S1070000015802 for generic pharmaceuticals and OTC products, due March 26, 2026, structured as a multistate cooperative vehicle. The code shows little recent relevant activity for azidamfenicol specifically, and pursuit should be qualified by direct inquiry into whether state and local health departments or emergency response agencies maintain standing demand for this particular product line.